Skip to main content
. 2023 Jan 18;11(1):e763. doi: 10.1002/iid3.763

Figure 1.

Figure 1

The enrichment of ACE2 in nasal mucosa. (A) The procedure for mice treatment. (B) The enrichment of ACE2 in the nasal mucosa of allergic rhinitis patients was determined by RT‐qPCR and (C) western blot analysis, n = 10, unpaired t test. (D) ACE2 levels in the nasal mucosa of allergic rhinitis mice were determined by RT‐qPCR and (E) western blot analysis, n = 3, unpaired t test. (F) ACE2 levels in the DIZE treatment group were assessed with RT‐qPCR and (G) western blot analysis, n = 5, Tukey's test. (H) The enrichment of ACE2 in the nasal mucosa of mice were determined using immunohistochemistry, magnification ×400. *p < .01 and ***p < .001. ACE2, angiotensin converting enzyme 2; DIZE, diminazene aceturate; OVA, ovalbumin; RT‐qPCR, reverse transcriptase‐quantitative polymerase chain reaction.